we examined the clinical relevance of a rise in fasting blood glucose ( bg ) between 0300 and 0600 in 97 patients with insulin-dependent diabetes mellitus ( iddm ) receiving sequentially conventional ( ct ) and basal-bolus ( bbit ) insulin therapies and assessed the impact of one potential causal factor , i.e. , posthypoglycemic hyperglycemia , with 231 bg profiles ( 97 during ct , 134 during bbit ) in which bg was measured every 3 h over a 24-h period .
C0011854
insulin-dependent diabetes mellitus
C0021641
insulin